Ethos Biosciences was formed as a subsidiary of Ott Scientific in 2018 to focus on the design, development, and manufacture of high quality, easy to use diagnostic test kits and reagents. In November 2018, Ethos Biosciences acquired the Exocell™ diagnostic operation in Philadelphia from Glycadia, Inc.
Exocell™ was founded in 1988 by Dr. Margo Cohen, MD/PhD to explore diagnostic and therapeutic solutions for diabetes. Exocell™ quickly became a leader in nephrology diagnostics with 15 patents and over 2000 research citations. Exocell™ continues to service the top research, academic, and industrial institutions in the world.
Ott Scientific is a family owned and operated group of specialty chemical manufacturing companies with expertise in monomers, polymers, microspheres, and reagents for the pharmaceutical, medical device, and diagnostic industries.
Our research diagnostics and reagents are used by the most prestigious scientific organizations in the world.